BR100 Increased By (0.22%)
BR30 Increased By (0.44%)
KSE100 Increased By (0.25%)
KSE30 Increased By (0.26%)
BECO 5.39 Decreased By ▼ -0.04 (-0.74%)
BML 56.50 Increased By ▲ 0.81 (1.45%)
BOP 35.45 Increased By ▲ 0.07 (0.2%)
CNERGY 8.19 Decreased By ▼ -0.01 (-0.12%)
DCL 11.58 Increased By ▲ 0.03 (0.26%)
FCCL 59.50 Increased By ▲ 1.14 (1.95%)
FCSC 5.15 Increased By ▲ 0.03 (0.59%)
FFL 17.75 Decreased By ▼ -0.09 (-0.5%)
FNEL 1.24 Decreased By ▼ -0.01 (-0.8%)
HUMNL 11.15 Increased By ▲ 0.08 (0.72%)
KEL 8.72 Decreased By ▼ -0.03 (-0.34%)
KOSM 6.76 Increased By ▲ 0.07 (1.05%)
MLCF 108.50 Increased By ▲ 1.35 (1.26%)
NBP 203.50 Increased By ▲ 1.77 (0.88%)
PACE 11.30 No Change ▼ 0.00 (0%)
PAEL 45.45 Increased By ▲ 0.96 (2.16%)
PIAHCLA 29.75 Increased By ▲ 0.34 (1.16%)
PIBTL 18.73 Increased By ▲ 0.09 (0.48%)
PPL 247.90 Decreased By ▼ -0.08 (-0.03%)
PRL 35.42 Increased By ▲ 0.13 (0.37%)
PTC 65.63 Decreased By ▼ -0.51 (-0.77%)
SEARL 96.17 Increased By ▲ 0.68 (0.71%)
SSGC 31.67 Decreased By ▼ -0.37 (-1.15%)
TELE 8.83 Decreased By ▼ -0.04 (-0.45%)
THCCL 66.50 Decreased By ▼ -0.11 (-0.17%)
TPLP 10.53 Decreased By ▼ -0.04 (-0.38%)
TREET 25.31 Increased By ▲ 0.01 (0.04%)
TRG 64.45 Increased By ▲ 0.05 (0.08%)
WAVES 11.03 Increased By ▲ 0.13 (1.19%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
By

LONDON: If coronavirus vaccinations are rolled out widely, life could return to "normal" by next winter, one of the scientists behind the front-running coronavirus vaccine told British television on Sunday. Ugur Sahin, the Turkish co-founder of German firm BioN, told the BBC's The Andrew Marr Show that "this winter will be hard" without any major impact from vaccinations.

Together with US giant Pfizer, BioN is developing the leading candidate in the worldwide chase for a vaccine, "If all goes well, we will start to deliver the vaccine at the end of this year, or beginning of next year," Sahin said. "Our goal is to deliver more than 300 million doses by April next year."

Comments

Comments are closed for this article.